The ageing eye by Amod, RC
As people age, most will inevitably encounter some changes in their 
vision that may be attributed solely to the ageing process. These 
processes are distinct from age-related eye diseases, although the 
visual changes they produce may be similar. One of the truest signs 
of ageing is the gradual loss of accommodation and the onset of 
presbyopia.  
With an increasing elderly population, age-related eye diseases are 
becoming the leading causes of vision impairment in the developed 
world. Many elderly patients are afflicted by more than one ageing 
eye condition, and these have a tremendous impact on their mental 
and social health and overall quality of life. Enormous strides are 
being made in understanding and preventing eye diseases. This 
article will focus on both the normal ageing processes of the eye 
and the common eye diseases that afflict the ageing patient.
Normal ageing of the e ye
The natural quality of vision gradually declines with the anatomical 
and physiological processes that occur with ageing of the human 
eye and visual system.  These changes include presbyopia, changes 
in the eyelids and tearfilm, and changes in the various intraocular 
structures contributing to the integrity of the visual system.
Presbyopia 
Presbyopia refers to the reduced ability to focus at close range as 
a result of loss of accommodation.  It is the most common ocular 
affliction in the world and is due to the decreased elasticity of the 
crystalline lens and reduced ciliary body tone that occurs with 
ageing.  The extent to which the lens power can be increased with 
accommodation slowly declines over the years and the innate 
ability to focus on objects located at varying distances becomes 
increasingly difficult. 
The average adolescent can comfortably accommodate up to 14D, 
and by age 45 this drops to about 4D and is completely gone by the 
age of 50 - 55.1  The rate of decline of accommodative amplitude 
occurs with very little inter-individual variability and is considered 
to be one of the most reliable biomarkers of human age known.2
Presbyopia usually manifests after 40 - 45 years of age.  Patients 
usually complain of increasing difficulty with near visual tasks such 
as reading fine print and find that small objects need to be held 
further from the eye in order to be seen clearly.
Treatment of presbyopia
In the early stages of presbyopia simply extending the arms and 
improving the lighting is adequate for reading.  Later, help in the 
form of reading glasses (plus lenses) becomes necessary. If distance 
corrective lenses are worn then the presbyopic correction may be 
incorporated as bifocal or multifocal spectacle lenses. If corrected 
with contact lenses the options include monovision, where one 
eye is corrected for distance vision and the other for near vision 
or bifocal contact lenses.  Refractive surgery for presbyopia has not 
yet been perfected. 
Eyelids
Ageing causes laxity of the eyelids due to involutional changes of 
the skin, orbicularis and levator muscles, tarsus and the canthal 
tendons. These changes contribute to the aetiology of several 
eyelid disorders such as lower lid inversion (entropion), lower lid 
eversion (ectropion) and aponeurotic ptosis of the upper lid. These 
conditions usually necessitate surgical correction.
Lens 
As the human eye ages, the lens continues to grow and becomes 
thicker due to the increasing deposition of outer cortical lens 
fibres.  This is accompanied by a gradual yellowing of the lens and 
a change in the refractive index – even before the development 
of cataract. As a result, the sensitivity of the eye to shorter blue 
wavelengths of light and the ability to discriminate blues and blue-
greens becomes reduced.2
Cornea  
The clarity of the cornea is maintained throughout life by the 
corneal endothelial cells. With ageing, the density of the endothelial 
cells decreases and their morphology changes, rendering the aged 
cornea more vulnerable to the stress of injury or intraocular 
surgery. 
Ageing and degeneration of the peripheral cornea is more benign 
and commonly manifests as the prominent white ring of arcus 
senilis.
Aberrations of the corneal surface also increase with age, resulting 
in refractive error, glare and reduced contrast. Referral to an 
optometrist for refraction is often beneficial. Dry eye also manifests 
frequently due to diminished aqueous tear production and this is 
treated with tear supplements. 
Vitreous
Progressive liquefaction of the vitreous gel occurs, manifesting 
as the occasional floater. These are benign and tend to be more 
of an annoyance than a visual impairment.  However, the age-
related separation of the vitreous gel from the retina, i.e. posterior 
vitreous detachment (PVD), may also manifest with floaters and 
may be complicated by retinal tears and retinal detachment. Hence 
any new-onset floaters and visual disturbances (flashes) mandate 
referral to an ophthalmologist for a dilated fundal examination and 
careful scrutiny of the peripheral retina.
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Ageing causes a general decline in retinal 
function (colour and contrast) due to the 
gradual loss of neuronal elements and an 
accumulation of waste material under the 
retina, called liposfuscin.  Regeneration of 
rhodopsin in photoreceptors slows down 
and there is reduced retinal illuminance 
due to the gradual reduction in pupil size 
(senile miosis), giving rise to night vision 
problems.  Therefore a 60-year-old receives 
about one-third of the light a 20-year-old 
receives – similar to wearing medium-
density sunglasses in bright light.3  
Age-related e ye disease 
Good visual acuity depends on the integrity 
of the various structures in the eye and visual 
pathways.  Therefore it is natural to expect 
that maintenance of good visual acuity 
into old age is an exception rather than 
the rule.   As the average life expectancy in 
developed countries is climbing, age-related 
eye diseases are becoming increasingly 
common, creating an enormous economic 
burden. These include cataract, glaucoma, 
age-related macular degeneration and the 
retinal complications of vascular diseases.
Age-related cataract   
Cataract refers to opacity of the crystalline 
lens of the eye and is the leading cause 
of treatable visual impairment affecting 
approximately 16 million people worldwide. 
Risk factors for developing cataract include 
increasing age, genetics, diabetes, ultraviolet 
exposure, nutrition, steroid use, smoking 
and trauma.4
Symptoms
•    Cataract typically produces gradual loss 
of vision in the affected eye.
•    Scattering of light by the cataract may 
cause monocular diplopia. 
•    Subcapsular cataracts may cause 
troublesome glare, especially when 
driving.
Signs
•    Loss of the red reflex or the presence of 
opacities in the red reflex.
•    An untreated mature white cataract is 
easily visible through the pupil. 
Morphological types of age-related 
cataract (Fig. 1)
•    Nuclear sclerosis – progressive yellowing 
of the centre of the lens. 
•    Cortical cataracts – peripheral spokes and 
radial water clefts. 
•    Posterior subcapsular cataract – opacity 
just beneath the posterior lens capsule. 
Treatment
As yet no effective method exists to prevent 
or halt the development of cataract. 
Studies to evaluate the role of nutritional 
supplements (carotenoids) or antioxidants 
(vitamins C and E) to delay cataract have 
been inconclusive.2  In the early stage the 
induced refractive change from the cataract 
can often be corrected with spectacles and 
may delay the need for surgery.
Surgery
Surgery is indicated when:
•    visual improvement is likely or 
•    the cataract is a risk to the eye, e.g. 
precluding a view of the retina in retinal 
disease or the cataract is inducing 
inflammation or angle closure glaucoma.
Tremendous advances have been made in 
cataract surgery in the last decade. Surgery 
is performed under topical anaesthesia 
via a small (< 3 mm) self-sealing corneal 
incision. High-frequency ultrasound 
(phaco-emulsification) is used to remove 
the cataract and a foldable intraocular lens 
(IOL) is then positioned within the capsular 
bag. Usually monofocal IOLs selected for 
optimal distance vision are implanted and 
reading glasses are used for near vision.  The 
newer multifocal and accommodating IOLs 
allow for unaided near and distance vision. 
Visual rehabilitation after cataract surgery 
is rapid and in the absence of co-morbid 
ocular disease, 92% of patients achieve a 
vision of 6/12 or better.5 Complications 
of cataract surgery are infrequent, with a 
0.01% risk of blindness from infection.  Late 
secondary deterioration of vision may result 
from new retinal pathology or opacification 
of the posterior lens capsule.  The opaque 
posterior capsule is easily excised using a 
photo-disruptive Nd:YAG laser and the 
visual axis is cleared.  
Glaucoma
Glaucoma describes a group of conditions 
characterised by progressive optic nerve 
damage with elevated intraocular pressure 
(IOP) being the major risk factor (see the 
article on glaucoma, p. 464 of this issue).
Age-related macular degeneration
Age-related macular degeneration (AMD) 
is defined as central vision loss attributable 
to degenerative atrophic and/or neovascular 
changes in the macula. The macula is the 
highly specialised central area of the retina 
used for fine visual acuity and colour vision.6 
Damage to this makes reading, writing and 
driving very difficult.  
AMD is the leading cause of irreversible 
visual impairment in the elderly worldwide, 
affecting an estimated 14 million people.6 
The disease tends to be bilateral although 
one eye may be affected long before the 
other.  The risk to the second eye is around 
50% within 5 years.  
The exact aetiology of AMD is not known 
but advancing age is a major risk factor.  A 
number of studies have linked smoking to 
the development of AMD.   Other associated 
risk factors include ultraviolet exposure, 
nutritional factors and genetic susceptibility. 
Compelling evidence is emerging that the 
innate immune system and the complement 
factor H gene play a vital role in the 
pathobiology of AMD.6   
Clinical features
Early AMD is characterised by the 
presence of yellow deposits (drusen) and 
pigmentary abnormalities in the macula. 
It is usually asymptomatic or causes mild 
visual impairment.  It denotes the risk of 
progression to late AMD (Fig. 2). 
Late AMD is divided into two types, i.e. wet 
(neovascular) and dry (non-neovascular) 
based on the clinical appearance of the 
macula. 
•    Dry AMD is most common and accounts 
for 85% of all cases of late AMD.  It 
develops slowly and causes gradual loss 
of central vision.  It is characterised by 
geographic atrophy of the retinal pigment 
epithelium (RPE). There is no treatment 
for dry AMD and patients usually require 
vitamins and low-vision aids.  
•    Wet AMD is less common and accounts for 
10 - 15 % of all cases of late AMD.  The onset 
is fairly rapid with an acute drop in central 
vision and distortion (metamorphopsia). 
Fig. 1. Senile cataract.
Fig. 2. Age-related macular degeneration.
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Wet AMD is characterised by the 
development of new vessels beneath the 
retina (choroidal neovascular membranes 
(CNV)), serous elevation (detachment) of 
the neurosensory retina and/or pigment 
epithelium and macular haemorrhages. 
End-stage disease demonstrates macular 
scarring. 
Neurospecial investigations
•    Fluorescein angiography confirms 
and localises the presence of CNV. Two 
major forms of CNV membranes may 
be defined, i.e. classic (well-defined) and 
occult (poorly defined).  
•    Optical coherence tomography (OCT) 
involves non-invasive retinal imaging 
technology depicting the layers of the 
retina and the underlying RPE.  It is used 
as an adjunct to fluorescein angiography to 
diagnose, monitor and guide treatment.
Management of AMD
There is neither a cure nor a means to 
prevent AMD. Early detection is crucial as 
all interventions are largely palliative and 
directed purely at minimising the vision loss 
associated with neovascular (wet) AMD.  
An Amsler grid may be given to patients for 
early detection of any change in their central 
vision.  This test is performed monocularly, 
wearing their near correction. The grid is 
held at 33 cm and any distortion is noted 
(Fig. 3). Any new distortion or field loss 
requires urgent specialist referral.
High-dose antioxidants and zinc have been 
postulated to prevent AMD and their role 
was explored in a large multicentre study 
(AREDS). The outcomes suggest that high-
dose supplements (Table I) can help to delay 
the progression of AMD in patients with 
either CNV in one eye, geographic atrophy 
or bilateral drusen, and long-term use is 
recommended in these patients.  The benefit 
of this formulation in patients with bilateral 
early AMD is less certain.  
Beta carotene is thought to confer a higher 
risk of lung cancer to smokers and is 
contraindicated. Cessation of smoking is 
also strongly advised. 
Current and upcoming therapies for AMD 
are outlined in Table I. The optimal timing 
and specific combination of therapy are not 
yet known.  Factors influencing the choice 
of regimen include the angiographic lesion 
type, the lesion composition and location 
and the patient affordability.  
Macular hole (Fig. 4)
Senile macular holes occurs spontaneously 
in the macula of elderly patients and result 
in loss of central vision (scotoma). They are 
believed to be caused by focal shrinkage 
of the vitreous and traction in the foveal 
area.  They usually affect one eye although 
there is a 10% chance that the other eye will 
eventually be affected.  Formation of the 
hole tends to occur in stages and may arrest 
at any stage.  A stage 4 macular hole refers 
to a full-thickness hole in the presence of a 
PVD.
Vascular disease and the 
ageing e ye
Age-related systemic vascular diseases are 
important risk factors for the development of 
ischaemic retinal diseases and the associated 
complications. Common presenting diseases 
include diabetes, hypertension, carotid artery 
disease, hyperlipidaemia, systemic vasculitis 
and hypercoagulability states.  Management 
of the ocular disease is directed towards the 
underlying cause and possible concurrent 
antiplatelet therapy to reduce systemic 
cardiovascular risk.7
Diabetes 
Manifests as diabetic retinopathy and/or 
maculopathy (see article on diabetes and the 
eye, p. 476 of this issue).
Retinal vein occlusion (branch 
(BRVO) or central (CRVO)) 
Retinal vein occlusions are the most 
common retinal vascular disease after 
diabetic retinopathy (Fig. 5). These patients 
present with acute vision loss or floaters. 
Typical ophthalmoscopic features include 
dilated and tortuous veins, intraretinal 
haemorrhages, cotton-wool spots, lipid 
exudates and retinal oedema. In CRVO 
these changes are widespread and in BRVO 
they are localised to the quadrant.
Management
Treatment is directed at:
•    diagnosis and management of the 
underlying cause and
•    prevention and management of 
complications, i.e. macular oedema and 
neovascularisation; complications depend 
on the extent of ischaemia and whether a 
collateral circulation is established. 
In CRVO, severe ischaemia usually results 
in neovascularisation of the iris (NVI), 
often complicated by neovascular glaucoma 
– a serious and blinding disease. In BRVO 
neovascularisation of the optic disc (NVD) 
and elsewhere in the retina (NVE) occurs 
and may result in vitreous haemorrhage. 
Treatment of neovascularisation is with 
retinal laser photocoagulation to prevent 
further complications. Laser treatment 
of macular oedema is only indicated in 
selected cases of BRVO.  However, ongoing 
Fig. 3. The Amsler grid with distortion.
Fig. 4. Optical coherence tomography demonstrating a macular hole.
Fig. 5. Central retinal vein occlusion.
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novel treatment options are being proposed, 
including intravitreal injections of vascular 
endothelial growth factor (VEGF) inhibitors 
or triamcinolone and decompression 
surgery. 
Anterior ischaemic optic neuroathy 
(AION) – arteritic and non-arteritic
AION is an infarction of the optic nerve 
head caused by occlusion of the short 
posterior ciliary arteries.  It is characterised 
by profound unilateral visual loss, optic disc 
swelling, relative afferent pupil defect and 
altitudinal visual field loss.  
 
•    Non-arteritic (NAION) may occur in 
isolation or in association with systemic 
vascular disease. The risk to the other eye 
is 5% per year.  The management is to 
treat the vascular risk factors and initiate 
antiplatelet agents such as aspirin. 
•    Arteritic AION is due to giant cell arteritis 
(temporal arteritis/giant-cell arteritis 
(GCA)) and typically affects patients over 
the age of 70.  The common presenting 
features include temporal headache 
with scalp tenderness, jaw claudication 
manifesting as pain on chewing, 
polymyalgia rheumatica and fever, weight 
loss and malaise. 
Management
Vision loss from GCA is an ophthalmo-
logical emergency as the risk of blindness in 
the fellow eye is almost 40% within 10 days 
if left untreated.7 The diagnosis of GCA is 
made on clinical grounds and verified with 
an elevated erythrocyte sedimentation rate 
(ESR) (> 60 mm/hr) and /or C-reactive 
protein. 
Treatment with high-dose steroids is usually 
instituted on clinical grounds while awaiting 
biopsy of the superficial temporal artery to 
confirm the diagnosis.  
Role of the GP in age-
related e ye disease 
Many elderly patients do not actively seek 
medical attention and accept that poor 
vision is an inevitable consequence of 
ageing.  General practitioners therefore have 
an important role to play in screening for, 
appropriately referring and co-managing 
visual impairment in older patients.  These 
responsibilities include:
•    To assess the severity and urgency of 
visual symptoms and refer appropriately 
(Table II). 
•    To become thoroughly familiar with the 
examination of the ageing eye and the 
clinical morphology of common diseases 
(Table III). Regular dilated fundal 
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Table I. Current treatment options for wet AMD
Treatment options Indications   Outcomes
Vitamin therapy         
(AREDS formulation)
500 mg vitamin C,  •  Severe AMD in fellow  Risk of developing 
400 IU vitamin E,      eye (foveal atrophy, CNV)  advanced AMD in 
15 mg beta-carotene  •  Moderate AMD (large  the fellow eye at 5 
and 80 mg zinc      drusen; extrafoveal atrophy) years reduced by 
Copper 2 mg       20 - 25%   
       NB! Beta carotene   
       contraindicated in  
       smokers
Argon laser  •   Extrafoveal CNV  Reduced risk of 
(thermal laser)  •   Limited role in juxtafoveal  severe visual loss
        membranes   Risk of recurrence  
       50%
Photodynamic therapy  Subfoveal and juxtafoveal CNV: Stabilises lesion: 
(PDT) 
IV Visudyne over 10 mins •   all small membranes  •   limits size of  
Non-thermal diode laser  •   predominantly classic      scotoma  
(689 nm) for 83 secs •   100% occult lesions  •  limits more vision     
           loss  
       Re-treatment   
       required at   
       3-monthly intervals
VEGF inhibitors  Any lesion type or location  •   Stabilises vision 
PegaptinibNa (Macugen)     •   May improve 
Bavacizumab (Avastin)         vision 
Ranizibumab (Lucentis)     •   Frequent 
Serial injections in eye          injections – small  
4 - 6- weekly indefinitely          risk (< 1%) of    
            cataract, infection,  
            retinal detachment
Macular translocation Subfoveal CNV – preferably  •   Successful 
Retina repositioned no previous laser        cases have visual  
surgically so macula lies           improvement 
on healthy RPE/choroid     •   Complication rate 
            high   
       •   Risk of total visual 
            loss
Table II. Indications for urgent referral
Vision
  •   Acute vision loss not correctable with pinhole
  •   Acute-onset visual phenomena – floaters, flashes 
  •   New-onset visual field defect
  •   Central scotoma, metamorphopsia or diplopia
Anterior segment
  •   Presence of RAPD 
  •   Dull cornea or positive staining with fluorescein
  •   Hard eye, shallow anterior chamber
  •   Neovascularisation of iris
Posterior segment
  •   Total loss of red reflex
  •   Disc swelling, pallor
  •   New haemorrhages – retinal or vitreous
  •   Neovascularisation of retina or disc
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examination in high-risk patients 
evaluating the retina, macula and optic 
disc. 
•    Important role in continued prescription 
of long-term eye drops and monitoring 
for systemic side-effects which may not 
be evident to the ophthalmologist. 
•    Patients with high-risk factors, e.g. 
family history of primary open-
angle glaucoma (POAG), should be 
informed of their risk and referred to 
an ophthalmologist for screening. 
•    Control of systemic risk factors 
(hypertension and diabetes) prior to 
elective surgery to avoid complications 
and cancellation of surgery.
•    General medical evaluation, screening 
and co-management of patients with 
eye manifestations of systemic diseases.
•    Supportive management for visually 
impaired patients in their occupation 
and daily activities and facilitating the 
best use of their remaining vision. 
•    Ongoing advice and encouragement to 
maintain ocular health, stop smoking 
and avoiding co-morbidities like falls, 
hip fractures, accidents and depression.
Conclusion 
As the average life expectancy increases 
worldwide, age-related eye diseases are 
becoming increasingly important and 
account for significant morbidity. Age is an 
important predictor of visual impairment 
and active screening for visual loss in 
the elderly should become part of the 
routine examination. Prompt referral to 
the ophthalmologist for the treatment of 
visual disorders may considerably reduce 
morbidity from eye disease.
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The ageing eye
Table III. Examining the ageing eye – specific features
Visual acuity tests
  •   Snellen visual acuity with pinhole vision
  •   Near vision assessment, colour vision
Eyelids
  •   Entropion or ectropion, horizontal lid laxity
  •   Elevated lid crease and ptosis
Pupils
  •   Relative afferent pupil defect
Anterior segment
  •   Arcus senilis, dry eye, corneal opacities
  •   Assessment of IOP (digital/tonometry)
 Red reflex
  •   Opacities, loss of red reflex
Optic nerve
  •   Cupping, disc haemorrhages, nerve fibre layer 
  •   Disc swelling, pallor, vasculature
Retinal vasculature
  •   Tortuousity, venous beading, new vessels
Retinal pathology
  •    Haemorrhages, hard exudates, cotton wool spots, macular oedema, degeneration, 
retinal detachment 
Visual fields
  •   Distortion on Amsler grid
  •   Altitudinal defect, central scotoma
In a nutshell 
•   Active screening for visual loss in the elderly should become routine.
•   The evaluation of visual impairment should include visual symptoms, visual acuity testing and detection of visual field changes.
•   Dilated fundal examination in high-risk groups is mandatory for early detection and timeous referral of treatable eye diseases.
•   Presbyopia usually presents adults over 40 years of age and is easily treated with reading glasses.
•   Cataracts are detected by the vision loss and opacities in the red reflex.
•    Early POAG is asymptomatic and the diagnosis is based on raised IOP > 21 mmHg, increased cupping of the optic disc and visual field 
changes.
•   Wet AMD is not curable or preventable and current treatments are largely directed at minimising visual loss.   
•    The management of retinal vascular diseases is directed towards early detection, treating the systemic cause and instituting antiplatelet 
therapy. 
•   Retinal vascular occlusions may be complicated by neovascularisation and macular oedema.
•   In giant-cell arteritis, treatment with high-dose steroids should not be delayed because the risk of fellow eye blindness is very high.
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